AN2 Therapeutics, Inc. (ANTX)

NASDAQ: ANTX · IEX Real-Time Price · USD
19.38
+7.61 (64.66%)
At close: Aug 12, 2022 4:00 PM
19.18
-0.20 (-1.03%)
After-hours: Aug 12, 2022 7:59 PM EDT

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020
Net Income
-21.54-13.6
Share-Based Compensation
0.970.04
Other Operating Activities
0.098.2
Operating Cash Flow
-20.48-5.36
Change in Investments
-50.020
Investing Cash Flow
-50.020
Share Issuance / Repurchase
0.010.06
Other Financing Activities
78.523.77
Financing Cash Flow
78.543.84
Net Cash Flow
8.03-1.53
Free Cash Flow
-20.48-5.36
Free Cash Flow Per Share
-7.76-2.09
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).